Short term outlook....bigger players are doing the once over on the company at the moment and if satisfied with their own due dilligence I am confident the price will surpass previous highs.
Long term outlook.....blockbuster wheezeometer prototype ready and should be in the market place early next year, in the meantime revenue's will be generated by the wim pc this year with massive world wide potential......distribution and marketing partners are now the key for significant company upside.
In the meantime Prof Gavriely and his team are beavering away back in Haifa preparing a warehouse full of new medical inovations that will roll out after the wim and wheezeometer success.
Take a lon term view, say 2-3 years and comparison's with Resmed and Cochlear will not seem far fetched.
Good luck if you dare;)
KSX Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
